when fda approve intellia therapeutics lonvo-z

    Before 2028

    when fda approve intellia therapeutics lonvo-z. Best Yes near 92¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 92¢ · Best No: 33¢ · 1 platform

    • Kalshi: Yes 92¢ / No 33¢
    TRADING OPEN

    Before 2028

    Volume

    $610

    $0 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolves Jun 30, 2027

    ~289 days left

    Category

    Culture

    92¢CHANCE OF YES74%26%
    Yes
    92¢
    Kalshi
    No
    33¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    kalshi
    Kalshi
    Best Yes
    Best No
    Yes
    92¢
    No
    33¢
    Vol
    $610
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jan 1, 2028, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 92¢: exit costs ~0.52¢/contract
    Full calculator

    Market Details

    ResolutionResolves Jun 30, 2027
    Time Left289 days
    Status● Active
    CategoryCulture

    Sign in to join the discussion

    Sign In